MedTrace Logo

Detection of Peritoneal Metastasis of Gastric Cancer by Liquid Biopsy in Peripheral Blood: A Prospective Study

NCT05347524 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 384

Last updated 2022-04-26

No results posted yet for this study

Summary

This study is a prospective, multi-omics, observational study aimed at detecting peritoneal metastasis of gastric cancer by combined assays for methylation of cell-free DNA (cfDNA) and other blood-based biomarkers. The study will enroll 384 participants with gastric cancer.

Conditions

Interventions

OTHER

Baseline blood draw and blood-based biomarkers analyses

Baseline blood draw and blood-based biomarkers analyses

Sponsors & Collaborators

  • Guangzhou Burning Rock Bioengineering Ltd.

    collaborator INDUSTRY

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Yihong Sun, Ph. D · Zhongshan Hospital, Fudan University, Shanghai, China

  • Xuefei Wang, Ph. D · Zhongshan Hospital, Fudan University, Shanghai, China

Eligibility

Min Age
18 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2023-12-31
Completion
2030-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05347524 on ClinicalTrials.gov